Reata Pharmaceuticals Inc (NASDAQ:RETA)

25.17
Delayed Data
As of Sep 30
 +0.14 / +0.56%
Today’s Change
18.47
Today|||52-Week Range
114.80
-4.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues50.3M49.9M48.1M53.6M
 
 
 
 
 
Depreciation And Amortization1.8M682.0K437.0K431.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses48.8M56.1M94.5M130.0M
 
 
 
 
 
Research And Development35.1M39.5M71.3M97.3M
 
 
 
 
 
Total Operating Expenses50.7M56.7M95.0M130.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-334.0K-6.9M-46.9M-76.9M
 
 
 
 
 
Extraordinary Charge0.000.000.00-1.0M
 
 
Interest Expense On Debt--0.001.5M6.2M
 
 
 
Other Expenses0.000.00-3.0K0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-302.0K-6.7M-47.7M-80.5M
 
 
 
 
 
Income Taxes-1.1M-441.0K-3.0K-26.0K
 
 
 
 
 
Net Income-1.5M-6.2M-47.7M-80.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS22.3M19.8M23.9M27.7M
 
 
 
 
 
Shares To Calculate EPS Diluted22.3M19.8M23.9M27.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.07-$0.31-$1.99-$2.91
 
 
 
 
 
EPS Diluted-$0.07-$0.31-$1.99-$2.91